Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. 1994

J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
Department of Pathology, University of Amsterdam, Netherlands.

CD44 variants containing v6 confer metastatic potential to rat carcinoma cell-lines. In man, CD44v6 is increasingly expressed during colorectal tumour progression. In 68 colorectal carcinoma patients, survival analysis showed that CD44v6 expression in the tumours was associated with tumour-related death. In patients who had an apparently radical resection of their primary tumour, CD44v6 expression had prognostic value independent of Dukes' stage. CD44v6 expression may reflect propensity for metastasis after apparently curative surgery, making adjuvant therapy an option in these patients.

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses
D016201 Receptors, Lymphocyte Homing Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules (addressins) on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes. Hermes Antigen Family,Homing Receptors, T-Cell,Lymphocyte Homing Receptors,Homing Receptor, Lymph Node,Lymph Node Homing Receptor,Receptor, Lymph Node Homing,Antigen Family, Hermes,Homing Receptors, Lymphocyte,Homing Receptors, T Cell,Receptors, T-Cell Homing,T-Cell Homing Receptors
D018960 Hyaluronan Receptors Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES. Antigens, CD44,CD44 Antigens,Hyaluronan-Binding Protein,Receptors, Hyaluronan,CD44 Antigen,Chondroitin Sulfate Proteoglycan 8,Hyaluronan Receptor,Hyaluronic Acid Binding Protein,Antigen, CD44,Hyaluronan Binding Protein,Receptor, Hyaluronan

Related Publications

J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
March 1995, Lancet (London, England),
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
March 1995, Lancet (London, England),
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
December 1998, Hematological oncology,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
November 2016, BMB reports,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
March 1998, Cancer letters,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
March 1998, Scandinavian journal of gastroenterology,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
July 1993, The Journal of cell biology,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
January 2000, Oncology reports,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
July 1997, Breast cancer research and treatment,
J W Mulder, and P M Kruyt, and M Sewnath, and J Oosting, and C A Seldenrijk, and W F Weidema, and G J Offerhaus, and S T Pals
December 1998, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!